# Fondazione Lanza

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/fondazione-lanza/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 65 |
| Citations | 52,092 |
| City | Padova |
| Country | IT |
| Description | Fondazione Lanza is a research organisation in Padova, IT. OpenAlex records 1,001 works and 52,092 citations for it. 233 researchers list it as their most recent affiliation. |
| Homepage | http://www.fondazionelanza.it/en/ |
| OpenAlex ID | https://openalex.org/I4210127950 |
| Researchers | 233 |
| ROR ID | https://ror.org/036kj7q93 |
| Type | other |
| Works | 1,001 |

## University papers

- [A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-exemestane-after-two-to-three-years-of-tamoxifen-therapy/)
- [Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial](https://scholariq.org/papers/cetuximab-plus-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer](https://scholariq.org/papers/combination-chemotherapy-as-an-adjuvant-treatment-in-operable-breast-cancer/)
- [Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial](https://scholariq.org/papers/survival-and-safety-of-exemestane-versus-tamoxifen-after-2-3-years-tamoxifen/)

## University top topics

Showing 8 of 25.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Heart Rate Variability and Autonomic Control](https://scholariq.org/topics/heart-rate-variability-and-autonomic-control/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
